Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa

Robert A Bonomo1, Dora Szabo

  • 1Louis Stokes Cleveland Dept. of Veterans Affairs Medical Center, Section of Infectious Diseases, Cleveland, Ohio 44106, USA. robert.bonomo@med.va.gov

Insights

Acinetobacter and Pseudomonas aeruginosa exhibit significant antibiotic resistance through enzymes like beta-lactamases and aminoglycoside-modifying enzymes. Multiple resistance mechanisms contribute to the rise of panresistant strains, posing a major clinical challenge.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Acinetobacter species and Pseudomonas aeruginosa are critical Gram-negative pathogens.
  • These bacteria possess intrinsic antibiotic resistance and readily acquire resistance genes.
  • Mechanisms of resistance are diverse and can accumulate, leading to multidrug resistance.

Purpose of the Study:

  • To review the primary mechanisms of antibiotic resistance in Acinetobacter species and Pseudomonas aeruginosa.
  • To highlight the role of specific enzymes and cellular processes in conferring resistance.
  • To underscore the clinical implications of accumulating resistance mechanisms.

Main Methods:

  • Literature review of antibiotic resistance mechanisms in Gram-negative bacteria.
  • Analysis of genetic and biochemical pathways involved in resistance.
  • Examination of clinical data on multidrug-resistant and panresistant strains.

Main Results:

  • Key resistance mechanisms include beta-lactamase production and aminoglycoside-modifying enzymes.
  • Reduced outer membrane protein expression, topoisomerase mutations, and efflux pump upregulation are significant.
  • The combination of these mechanisms results in strains with extensive or complete resistance to antibiotics.

Conclusions:

  • Acinetobacter and Pseudomonas aeruginosa employ a variety of mechanisms to resist antibiotics.
  • The cumulative effect of these mechanisms leads to the emergence of highly resistant strains.
  • Understanding these resistance pathways is crucial for developing effective therapeutic strategies.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...